Q32 Bio Inc. (QTTB) Share-based Compensation (2017 - 2026)

Q32 Bio has reported Share-based Compensation for 10 years, with the latest figure at $2.3 million in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 18.54% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $2.3 million, a 18.54% increase from a year earlier, with the FY2025 full-year figure at $8.0 million, down 36.51% from the prior year.
• Share-based Compensation was $2.3 million for Q2 2026 at Q32 Bio, down from $2.3 million in the prior quarter.
• The five-year high for Share-based Compensation was $12.8 million in Q2 2023, with the low at $521000.0 in Q4 2023.
• Average Share-based Compensation over 5 years is $5.0 million, with a median of $2.2 million recorded in 2024.
• The largest YoY upside for Share-based Compensation was 140.12% in 2024 against a maximum downside of 83.9% in 2024.
• Over 5 years, Share-based Compensation stood at $3.1 million in 2022, then sank by 83.13% to $521000.0 in 2023, then surged by 140.12% to $1.3 million in 2024, then climbed by 17.43% to $1.5 million in 2025, then soared by 53.33% to $2.3 million in 2026.
• The last three Share-based Compensation figures came in at $2.3 million (Q2 2026), $2.3 million (Q1 2026), and $1.5 million (Q4 2025), per Business Quant data.